Clinical trial
Active Immunotherapy Against HIV During Highly Active Anti-retroviral Therapy Followed by Repeated Treatment Interruptions
NCT01140139 is registered in ClinicalTrials.gov with Swedish Institute for Infectious Disease Control as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Active Immunotherapy Against HIV During Highly Active Anti-retroviral Therapy Followed by Repeated Treatment Interruptions
- Lead sponsor
- Swedish Institute for Infectious Disease Control
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- December 31, 2009
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv-1